🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#ShenderovLab latest publication is now at npj Journals rdcu.be/ckCSd. Our multiple-instance deep learning model for APL is an important proof of principle for rapidly identifying t(15;17) #APL from peripheral smear - especially important for low resource settings.

I met Eugene Shenderov, MD DPhil FACP at the @bloombergkimmel retreat a few yrs ago and we immediately hit it off. After spending an hour chatting in the parking lot, he proposed a potential collaboration. Our manuscript is now available at npj Journals Precision Oncology! nature.com/articles/s4169…

Our paper to accelerate clinical development of NY-ESO-1-targeted therapies. Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1 peptide jitc.bmj.com/content/9/6/e0… NIH University of Oxford Johns Hopkins Medicine

#PCFfunded Young Investigators Drs. Joaquin Mateo and Eugene Shenderov, MD DPhil FACP Chair & lead panel discussion on #ASCO21 Oral Abstract Session for Genitourinary Cancer w/ #ProstateCancer expert clinical trialists Drs. silke gillessen Neeraj Agarwal, MD, FASCO, Karim Fizazi & Lisa Horvath. Prostate Cancer Foundation

New #JITC article: Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1157-165 tumor-specific peptide Jon Silk Eugene Shenderov, MD DPhil FACP ow.ly/JKVU50F5xBV

Risks and Benefits of #Immunotherapy Versus Chemotherapy in Patients With Advanced #ProstateCancer [dailynews.ascopubs.org/do/10.1200/ADN…] #ASCODailyNews ASCO

Join us July 21 at 3:30 PM ET for a live ASCO #AM21 Post-Plenary Discussion of abstract LBA4 (VISION). Open to all Annual Meeting registrants. Visit conferences.asco.org/am/post-plenar… for more info

The situation in Ukraine is one of unfathomable tragedy. Fighting needs to stop. Sanity needs to prevail. Insanity to see explosions on the largest nuclear plant in Europe at Zaporizhzhia! #UkraineRussianWar #Zaporizhzhia

"As citizens we must work toward peace; as clinicians we must strive to heal & provide hope in the despair of illness." Eugene Shenderov, MD DPhil FACP Johns Hopkins Medicine @bloombergkimmel @DrJRubenstein Dr Rachel Clarke Elizabeth Gundersen Ambereen K. Mehta, MD, MPH, FAAHPM Nathan Gray MD, FACP Dr Ros Taylor 💜 tinyurl.com/22hk77zz

New ACS Journal Cancer article: acsjournals.onlinelibrary.wiley.com/share/4IKDRTN4… with Tamara Lotan, MD. B7-H3 is evolving into a fascinating target for prostate cancer. Prostate Cancer Foundation Johns Hopkins Medicine

Thank you to ASCO for naming me an Advocacy Champion at the #ASCOAdvocacySummit. I am proud to advocate on issues including access to cancer clinical trials, increased funding for NIH, and increased access to #telehealth. Get involved today.

swimacrossamerica.org/site/TR/PoolSw… Looking forward to my first swim against cancer with Swim Across America on September 11th 2022. Please donate for cancer research.

Delighted to share our European Urology European Urology Editorial on B7-H3 as a therapeutic dance partner for prostate cancer. europeanurology.com/article/S0302-…

Excited to share a promising immunotherapy targeting B7-H3 for prostate cancer. hopkinsmedicine.org/news/newsroom/… via Hopkins Med News Johns Hopkins Kimmel Cancer Center Nature Medicine rdcu.be/c83tH

Fruition of an incredible amount of teamwork and with deep appreciation for all the patients who put their trust in Johns Hopkins Kimmel Cancer Center as well as funders including MacroGenics, Inc. CDMRP Prostate Cancer Foundation Conquer Cancer, the ASCO Foundation

At the Capitol with the #Maryland #ASCOAdvocacySummit advocating for improved cancer care. ⁦ASCO⁩ ⁦Qasim Hussaini, MD⁩ ⁦P Celano⁩ ⁦Joshua Reuss⁩

Alum Eugene Shenderov, MD DPhil FACP presented work on B7-H3 as a novel therapeutic target for advanced prostate cancer at Prostate Cancer Foundation scientific retreat PCF Science @PCFNews #PCFRetreat23 #NIHOxCamScholars

Advocating for cancer patients. #ASCOAdvocacySummit

⁦Delighted to be part of the conversation to create the AI Future in Cancer Research. ⁦Stand Up To Cancer⁩ ⁦Computer History Museum⁩

Dr Eugene Shenderov, MD DPhil FACP presenting his phase 2 trial for neoadjuvant therapy prior to radical prostatectomy. Mohamad Allaf Amer. Urol. Assn. #AUA24